PATENT CLAIM ANALYSIS

Application Number: 16404027
Application Type: Utility
Filing Date: 2019-05
Publication Date: 2019-09
Patent Classification: ["424", "489000"]

Abstract:
The present invention relates to the field of methods for providing pharmaceutical compositions comprising poorly water-soluble drugs. In particular the present invention relates to compositions comprising stable, amorphous hybrid nanoparticles, comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component, useful in pharmaceutical compositions and in therapy.

Claim (Index 77):
The pharmaceutical composition of  claim 76 , wherein the amount of protein kinase inhibitor, based on the total weight of particles, is from about 10% by weight to about 40% by weight.

Metadata:
- Claim Count in Document: 161.0
- Percentile: 100.0
- Lexical Diversity: 1.48718
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16404004', '15791093', '15248107', '16403969', '16404059']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9063945326705136
- 35 USC 102 Novelty (BERT): 0.6941422144950092
- Combined Prediction Score: 0.8851693008529632
- Mean Citation Score: 847.2022400000003
- Max Citation Score: 854.8287
- Similarity Product: 701.253825257367

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test